The latest at the Foundation | Access to Medicine Foundation

Is the industry making progress on improving access to medicine?

18 November 2022

What are pharma companies doing to expand access to insulin – and how can efforts be scaled up?

06 October 2022

Index finds more pharma companies moving to address access to medicine. Will they now go further?

15 November 2022

Gas companies took action during COVID-19. Now they must expand access to medical oxygen over the long term.

Resource Center

Explore our research reports and publications

First-of-its-kind framework to assess how generics manufacturers expand access to medicine

15 February 2023

New Supervisory Board members Linda-Gail Bekker and Mariângela Simão bring a world of experience

Lack of access to antibiotics and antifungals compromise cancer care

23 November 2022

How companies perform on ensuring access to their SRHR-related products for women and girls in LMICs

25 November 2022

GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking.

From insulin to glucose self-monitoring devices: ramping up access along the diabetes continuum of care

Poor countries desperately need better access to generic medicines

15 February 2023

Joint roundtable with Chatham House identifies key opportunities for expanding access to medical oxygen

12 December 2022

Achievements so far

Read more about the Foundation's impact

Closing the gaps in access to diabetes care in low- and middle-income countries

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries